Short answer
No cannabis product has FDA approval for diabetic nerve pain. Nerve pain is not on the approved list.
Clinical trials give mixed results. Products that contain THC, including smoked cannabis and the oral spray nabiximols, lowered neuropathic pain by a small amount in some studies. Trials of CBD alone for nerve pain are few and small. A 2018 Cochrane review rated the evidence for cannabinoids in neuropathic pain as low quality.
Cannabis Diabetic Diet Recipes: Low-Sugar Edibles Guide
How common is diabetic nerve pain
About half of people with diabetes develop some form of nerve damage, per the CDC. Symptoms include burning, tingling, numbness, and stabbing pain in the feet and hands. High blood glucose damages nerves over years. Damage can continue after glucose control improves.
Best Cannabis Strains for Diabetes: A Practical Comparison
What "cannabis oil" covers
The term describes several products. They do not act the same way.
Cannabis Effects on Insulin Resistance: A Comprehensive Guide
- Tinctures and oils with THC and CBD, held under the tongue or swallowed.
- CBD isolate products made from hemp, with THC at or below 0.3% dry weight.
- Concentrated extracts, sold as RSO, with high THC content.
- Topical balms and salves, which act on the skin and reach the bloodstream in small amounts.
Labels list milligrams of THC and CBD per bottle and per dose. A 10 mg dose means 10 mg of one named cannabinoid, not 10 mg of oil.
THC and CBD hit different targets
THC binds CB1 and CB2 receptors. CB1 receptors sit on nerve cells and in the brain. THC changes pain signaling and pain perception. It also causes impairment, fast heart rate, and anxiety in some users.
CBD does not bind CB1 with strength. It acts on other channels, including TRPV1 and serotonin receptors. Lab work points to an anti-inflammatory effect. Human trials for nerve pain are limited.
Blood sugar and drug interactions
Cannabis does not replace insulin, metformin, or other glucose-lowering drugs. Studies on cannabis and A1C give mixed results. Some show lower fasting glucose in users. Others show no change.
CBD blocks the CYP3A4 and CYP2C19 enzymes in the liver. Those enzymes break down many prescription drugs. CBD can raise blood levels of some medications. Ask a pharmacist to review your full list.
Legal status in the US
Under federal law, cannabis with more than 0.3% THC is Schedule I. Hemp-derived CBD at or below 0.3% THC is legal under the 2018 Farm Bill. State rules differ. Medical cannabis programs in most states list neuropathy as a qualifying condition. Check your state program rules.
Dosing
No standard dose exists for nerve pain. Trials used a wide range of THC doses. Some studies gave 2.5 mg per day. Others gave 30 mg or more. Start low if you try a product. Keep a written log of dose, time, and pain score. Do not drive after THC.
Risks
- Dizziness and falls in older adults.
- Memory and attention problems during use.
- Dependence. About 3 in 10 people who use cannabis develop cannabis use disorder, per NIDA.
- Cannabis hyperemesis syndrome, with repeated vomiting.
- Lung harm from smoking or vaping. Oral oil avoids this route.
What to ask your clinician
- Does my current medication interact with CBD or THC?
- What dose range is safe given my age and other conditions?
- How do I track pain and blood sugar at the same time?
- Which state program and lab test should I check?
Options with strong evidence
Neuropathy care with solid evidence includes glucose control, foot checks, and prescription drugs such as duloxetine, pregabalin, gabapentin, and topical capsaicin. Cannabis may sit alongside those options. It does not replace them.